Evidence map›Paper›PMID 40548092›Full record

ArticleApplied biosafety : journal of the American Biological Safety Association2025

Dual-Use Research of Concern Landscape in Southeast Asia: Prioritization, Gaps, and Challenges.

Mely Caballero-Anthony, Jose Ma Luis Montesclaros, Jeselyn, Julius Cesar Trajano

Abstract read
In one paragraph

Article in Applied biosafety : journal of the American Biological Safety Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mely Caballero-AnthonyCentre for Non-Traditional Security Studies, S. Rajaratnam School of International Studies, Nanyang Technological University, Singapore, Singapore.
Jose Ma Luis MontesclarosCentre for Non-Traditional Security Studies, S. Rajaratnam School of International Studies, Nanyang Technological University, Singapore, Singapore.
JeselynCentre for Non-Traditional Security Studies, S. Rajaratnam School of International Studies, Nanyang Technological University, Singapore, Singapore.
Julius Cesar TrajanoCentre for Non-Traditional Security Studies, S. Rajaratnam School of International Studies, Nanyang Technological University, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article examines the governance of dual-use research of concern (DURC) in Southeast Asia, highlighting both progress and persistent gaps in biosafety and biosecurity. While significant developments have been made in biosafety and biosecurity, the region remains underprepared to address the complexities of DURC. This underpreparedness stems from diverse factors, including varying levels of exposure to biosecurity threats across countries, competing priorities within national biosecurity agendas, limited awareness of DURC issues, and weak institutional capacity to implement effective oversight mechanisms. These factors create inconsistencies in the implementation of DURC governance across countries, undermining efforts to establish robust safeguards against potential misuse of scientific research. The article argues that addressing these domestic issues is crucial for building more effective DURC governance frameworks. Strengthening national policies, improving institutional capabilities, and fostering awareness of DURC risks are essential steps toward mitigating biosecurity threats and ensuring the responsible conduct of research within the region.

Indexed as

biological riskbiosecuritybiosecurity governancedual-use research of concernSoutheast Asia

Identifiers

PMID40548092
PMCPMC12179371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.